Caricamento...
Improved bioavailability of cromolyn sodium using inhaled PA101 delivered via eFlow® nebulizer
In 1960s, cromolyn sodium (CS) has been introduced as the first non-steroidal anti-inflammatory drug for the treatment of allergic and mast-cell driven diseases. Its applicability has been limited due to a poor bioavailability. Here we present pharmacokinetic data of a novel high concentration formu...
Salvato in:
| Pubblicato in: | Eur Clin Respir J |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Taylor & Francis
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7480408/ https://ncbi.nlm.nih.gov/pubmed/32944204 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/20018525.2020.1809083 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|